Poliovirus Receptor anticorps (AA 35-50, AA 60-80)

N° du produit ABIN219957

Cet anticorps anti-Poliovirus Receptor est un anticorps Souris Monoclonal détectant Poliovirus Receptor dans FACS et IF. Adapté pour Humain et Singe.

Aperçu rapide pour Poliovirus Receptor anticorps (AA 35-50, AA 60-80) (ABIN219957)

Antigène: Poliovirus Receptor (PVR)

Reactivité: Humain, Singe

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp Poliovirus Receptor est non-conjugé

Application: Flow Cytometry (FACS), Immunofluorescence (IF)

Détail du produit anti-Poliovirus Receptor anticorps

Épitope: AA 35-50, AA 60-80

Specificité: Recognizes human CD155/ PVR. Species cross-reactivity: monkey. Does not react with porcine, canine, rabbit, rat, hamster and mouse.

Purification: Protein G purified

Immunogène: HeLa cells. Epitope: aa35-50. Cellular Localization: Cell membrane. MW of Antigen: 60-80kD.

Type of Immunogen: Cells

Isotype: IgG1

Information d'application

Indications d'application: Approved: Flo, IF

Usage: Suitable for use in Flow Cytometry and Immunofluorescence

Commentaires:

Target Species of Antibody: Human

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: Lot specific

Buffer: 10 mM PBS,  pH 7.4, 0.2 % BSA, 0.09 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Avoid freeze-thaw cycles.

Stock: 4 °C,-20 °C

Stockage commentaire: Short term: 4°C. Long term: Store at -20°C. Avoid freeze-thaw cycles.

Détails sur Poliovirus Receptor

Antigène: Poliovirus Receptor (PVR)

Autre désignation: PVR / CD155

Sujet: Name/Gene ID: PVR

Synonyms: PVR, CD155, Hpvr, HVED, Nectin-like 5, Nectin-like protein 5, Poliovirus receptors beta, Poliovirus receptor, PVS, Necl-5, CD155 antigen, NECL5, TAGE4

ID gène: 5817

UniProt: P15151

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Cancer Immune Checkpoints, SARS-CoV-2 Protein Interactome